Archives

by in
Entry Author Date Location
PATH Snags $1M Federal Grant to Take Ultra Rice to Africa 10/20/10 Seattle
OncoGenex Raises $50M 10/19/10 Seattle
Sangamo, With a Lock on Genetic Switch Technology, Seeks to Morph Into Drugmaker 10/18/10 San Francisco
Anadys Raises $25M 10/15/10 San Diego
Omeros Addiction Program Wins NIH Grant 10/14/10 Seattle
Prop. 24 Will Hurt California Businesses, Big and Small 10/13/10 San Francisco
NanoBio, U-M Nab $1.5M to Treat Combat Injuries 10/12/10 Detroit
Sunesis Adds $15.5M 10/01/10 San Francisco
Rigel Nabs $25M From AstraZeneca 09/29/10 San Francisco
Sanford-Burnham Gets $21M Grant 09/28/10 San Diego
Oncothyreon Raises $14.9M 09/24/10 Seattle
Infinia, InnovaTek Win U.S. Grants 09/16/10 Seattle
ZymoGenetics Reaches the End, Stratos Genomics Nabs $4M, Children’s New Ventilator, & More Seattle-Area Life Sciences News 09/09/10 Seattle
Swedish Names Chief Scientist 09/08/10 Seattle
The Feds Need to Start Supporting Early-Stage Drug Development 09/02/10 Seattle
Complete Genomics Adds $39M 08/19/10 San Francisco
Nuon Adds $10M Debt, Options 08/12/10 San Francisco
EE Tech Gets $280K; Army Backing 08/04/10 Seattle
Dendreon Misses Wall Street’s (Already Low) Expectations for Provenge Sales 08/03/10 Seattle
Dendreon Watchers: Buckle Up for Action in First Quarterly Report With Actual Sales 08/03/10 Seattle
Complete Genomics Seeks IPO 08/02/10 San Francisco
LS9 Reveals Key Biofuel Genes, Onyx Drug Passes Big Trial, Solazyme Seeks First-Mover Edge, & More Bay Area Life Sciences News 07/30/10 San Francisco
Omeros Lines Up $40M Financing 07/29/10 Seattle
Marina Gets RNAi Delivery Tools for $5M 07/28/10 Seattle
Gilead Borrowing $2.2B 07/26/10 San Francisco
Biotech on a Shoestring? There’s a Better Way 07/26/10 San Diego
Genzyme Stock Surges 15 Percent on Sanofi Buyout Speculation 07/23/10 Boston
MDRNA Does Reverse Stock Split 07/21/10 Seattle
Oncothyreon Lines Up $20M 07/07/10 Seattle
Motricity Completes IPO, Settles For $50M 06/18/10 Seattle
Page 5 of 11 « previous page · next page »